Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01461395 · ClinicalTrials.gov registry record

Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm

A clinical trial, sponsored by University of South Florida.

Completed
Registry status
84
Enrollment target

NCT01461395 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01461395 has completed, sponsored by University of South Florida.

COMPLETED
Registry status
84 participants
Enrollment target

Study Summary

The purpose of this study is to find a non-invasive way to discover DNA (deoxyribonucleic acid, which is the genetic material inside your cells) alterations in the sperm's head, in the near future leading us to choose the "good sperm" in a simplified manner. This could then increase chances of a successful in-vitro fertilization (IVF) treatment when there are sperm abnormalities.

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2008-10
Est. Completion 2012-06

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT01461395

The ClinicalTrials.gov registry entry for NCT01461395 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01461395 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01461395 about?

NCT01461395 is a clinical study titled "Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm". The purpose of this study is to find a non-invasive way to discover DNA (deoxyribonucleic acid, which is the genetic material inside your cells) alterations in the sperm's head, in the near future leading us to choose the "good sperm" in a simplified manner. This could then increase chances of a suc...

What is the current status of trial NCT01461395?

This trial is currently completed. The enrollment target is 84 participants. The study started on 2008-10. Estimated completion is 2012-06.

Who is sponsoring clinical trial NCT01461395?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.